Robert Millonig, Ph.D., Deepa Shiwcharan Pharm.D. Companies interested in researching, developing, and commercializing pharmaceutical compounds should be aware of not only strategies for patenting the ...
Polymorphs are not mythical, chimeric beasts—they are substances with identical chemical compositions but differing crystal structures that also exhibit different physical and chemical properties.
In this interview, Dr. Matteo Daldosso, Physical Properties Unit manager at Aptuit and Dr. Sebastian Wegner, Product Manager of Solid-state NMR at Bruker Biospin, discuss novel solutions for solid ...
MADISON, Wis.--(BUSINESS WIRE)--New research by Usona Institute identifies the most favorable environments to achieve consistency and reproducibility of pharmaceutical psilocybin produced at large ...
Hosted on MSN
Scientists redesign common deworming drug to kill cancer cells... and it could even prevent the deadly disease
What is being hailed as a 'cancer treatment breakthrough' comes not from a brand-new experimental drug, but from a 40-year-old medicine used to treat worms. Researchers from Johns Hopkins University ...
Jicheng Yang of Wanhuida Intellectual Property considers whether a notable Beijing Intellectual Property Court decision signals a change to assessing inventive step in polymorph patents in China On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results